Literature DB >> 2433338

Analysis of the interaction of antibodies with immunoglobulin idiotypes on neoplastic B lymphocytes: implications for immunotherapy.

T J Elliott, M J Glennie, H M McBride, G T Stevenson.   

Abstract

We have examined the reactions of a panel of nine monoclonal anti-idiotype antibodies with the surface immunoglobulin in situ on guinea pig L2C leukemic lymphocytes. Equilibrium binding constants were shown to range between 10(7) and 10(8) M-1 for univalent Fab' gamma fragments and between 10(8) and 10(9) M-1 for intact IgG. Saturation of the cell surface binding sites was achieved with 2.9 X 10(5) Fab' gamma molecules/cell and 1.2 X 10(5) IgG molecules/cell for each antibody, a result that is consistent with a bivalent mode of interaction for the IgG. Despite these overall similarities in binding characteristics antibodies showed striking differences in their ability to clear Ig from the cell surface by antigenic modulation in vitro. This suggested differences in the readiness with which the antibodies cross-linked neighboring surface Ig molecules. Such an interpretation was supported by differences in the times required to achieve bivalent binding at 0 degree C, and in the rates at which labeled antibody dissociated from the cell surface in the presence or absence of an excess of unlabeled antibody. The data are consistent with there being two functionally distinct types of anti-idiotype antibody: those that form predominantly intra-Ig bridges, with each antibody Fab being linked to an Fab on one target molecule ("monogamous" binding) and not favoring modulation; and those that form predominantly inter-Ig bridges ("bigamous" binding) and favor modulation. The nature of interaction is presumably dictated by the orientation of the particular idiotope concerned. This distinction could be of great importance in the therapeutic use of anti-idiotype to ablate B cell neoplasms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433338

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Membrane Ig-mediated triggering of B cell tolerance and B cell clonal expansion: implications for rheumatoid factor production in rheumatoid synovitis.

Authors:  P K Mongini; S M Rudich
Journal:  Springer Semin Immunopathol       Date:  1989

2.  Allorecognition of purified major histocompatibility complex glycoproteins by cytotoxic T lymphocytes.

Authors:  T J Elliott; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

3.  The role of apoptosis in antibody-dependent cellular cytotoxicity.

Authors:  S J Curnow; M J Glennie; G T Stevenson
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

Review 4.  Three major uncertainties in the antibody therapy of cancer.

Authors:  George T Stevenson
Journal:  Haematologica       Date:  2014-10       Impact factor: 9.941

5.  Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression.

Authors:  Ali Roghanian; Guangan Hu; Christopher Fraser; Maneesh Singh; Russell B Foxall; Matthew J Meyer; Emma Lees; Heather Huet; Martin J Glennie; Stephen A Beers; Sean H Lim; Margaret Ashton-Key; Stephen M Thirdborough; Mark S Cragg; Jianzhu Chen
Journal:  Cancer Immunol Res       Date:  2019-08-26       Impact factor: 11.151

6.  Ligation of CD11c during vaccination promotes germinal centre induction and robust humoral responses without adjuvant.

Authors:  Ann L White; Alison L Tutt; Sonya James; Kevin A Wilkinson; Fernanda V V Castro; Sandra V Dixon; Jessica Hitchcock; Mahmood Khan; Aymen Al-Shamkhani; Adam F Cunningham; Martin J Glennie
Journal:  Immunology       Date:  2010-05-10       Impact factor: 7.397

7.  Comparative efficiencies of bispecific F(ab'gamma)2 and chimeric mouse/human IgG antibodies in recruiting cellular effectors for cytotoxicity via Fc gamma receptors.

Authors:  J Greenman; N Hogg; S Nikoletti; C Slade; G Stevenson; M Glennie
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

8.  Emergence of immunoglobulin variants following treatment of a B cell leukemia with an immunotoxin composed of antiidiotypic antibody and saporin.

Authors:  M J Glennie; H M McBride; F Stirpe; P E Thorpe; A T Worth; G T Stevenson
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

9.  Anti-IgM-mediated B cell signaling. Molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance.

Authors:  S M Rudich; K H Roux; R J Winchester; P K Mongini
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

10.  Affinity and kinetic analysis of the interaction of the cell adhesion molecules rat CD2 and CD48.

Authors:  P A van der Merwe; M H Brown; S J Davis; A N Barclay
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.